Patents by Inventor Elizabeth Allan

Elizabeth Allan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Albumin derivatives and variants
    Patent number: 10233228
    Abstract: The application discloses albumin derivatives comprising or consisting of domain III and at least one further domain wherein the derivative or variant is not a naturally occurring albumin derivative or variant. The derivatives may be used in conjugates and fusion polypeptides.
    Type: Grant
    Filed: April 8, 2011
    Date of Patent: March 19, 2019
    Assignee: ALBUMEDIX LTD
    Inventors: Andrew Plumridge, Darrell Sleep, Inger Sandlie, Jan Terje Andersen, Jason Cameron, Leslie Evans, Steven Athwal, Elizabeth Allan, Esben Peter Friis
  • Methods for one step nucleic acid amplification of non-eluted samples
    Patent number: 10053686
    Abstract: The present invention relates to methods and kits which can be used to amplify nucleic acids with the advantage of decreasing user time and possible contamination. For easy processing and amplification of nucleic acid samples, the samples are bound to a solid support and used directly, without purification, in a nucleic acid amplification reaction such as the polymerase chain reaction (PCR).
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 21, 2018
    Assignee: GE HEALTHCARE UK LIMITED
    Inventors: Michael Kenneth Kenrick, Aidan Mark Emery, Fiona Elizabeth Allan, Bonnie Lee Webster, Erik Leeming Kvam, Wei Gao
  • Benzylamine derivatives
    Patent number: 9834513
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: December 5, 2017
    Assignee: Kalvista Pharmceuticals Limited
    Inventors: Christine Elizabeth Allan, Andrzej Roman Batt, Rebecca Louise Davie, Hannah Joy Edwards, David Michael Evans, Stephen John Pethen
  • Benzylamine Derivatives
    Publication number: 20170253561
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.
    Type: Application
    Filed: May 23, 2017
    Publication date: September 7, 2017
    Inventors: Christine Elizabeth Allan, Andrzej Roman Batt, Rebecca Louise Davie, Hannah Joy Edwards, David Michael Evans, Stephen John Pethen
  • Benzylamine derivatives
    Patent number: 9670157
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.
    Type: Grant
    Filed: January 8, 2014
    Date of Patent: June 6, 2017
    Assignee: Kalvista Pharmaceuticals Limited
    Inventors: Christine Elizabeth Allan, Andrzej Roman Batt, Rebecca Louise Davie, Hannah Joy Edwards, David Michael Evans, Stephen John Pethen
  • BENZYLAMINE DERIVATIVES
    Publication number: 20160039752
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.
    Type: Application
    Filed: January 8, 2014
    Publication date: February 11, 2016
    Inventors: Christine Elizabeth ALLAN, Andrzej Roman BATT, Rebecca Louise DAVIE, Hannah Joy EDWARDS, David Michael EVANS, Stephen John PETHEN
  • METHODS FOR ONE STEP NUCLEIC ACID AMPLIFICATION OF NON-ELUTED SAMPLES
    Publication number: 20160017315
    Abstract: The present invention relates to methods and kits which can be used to amplify nucleic acids with the advantage of decreasing user time and possible contamination. For easy processing and amplification of nucleic acid samples, the samples are bound to a solid support and used directly, without purification, in a nucleic acid amplification reaction such as the polymerase chain reaction (PCR).
    Type: Application
    Filed: March 14, 2014
    Publication date: January 21, 2016
    Inventors: Michael Kenneth Kenrick, Aidan Mark Emery, Fiona Elizabeth Allan, Bonnie Lee Webster, Erik Leeming Kvam, Wei Gao
  • Amphetamine Prodrugs
    Publication number: 20140073589
    Abstract: The present invention relates to amphetamine prodrugs which provide colonic release of amphetamine.
    Type: Application
    Filed: June 26, 2013
    Publication date: March 13, 2014
    Inventors: Rhys WHOMSLEY, Christine Elizabeth Allan, Timothy Jon Luker
  • Albumin Derivatives and Variants
    Publication number: 20130028930
    Abstract: The application discloses albumin derivatives comprising or consisting of domain III and at least one further domain wherein the derivative or variant is not a naturally occurring albumin derivative or variant. The derivatives may be used in conjugates and fusion polypeptides.
    Type: Application
    Filed: April 8, 2011
    Publication date: January 31, 2013
    Applicant: NOVOZYMES BIOPHARMA DK A/S
    Inventors: Andrew Plumridge, Darrell Sleep, Inger Sandlie, Jan Terje Andersen, Jason Cameron, Leslie Evans, Steven Athwal, Elizabeth Allan, Esben Peter Friis
  • Aminopyridine Derivatives
    Publication number: 20100076015
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (such as asthma or COPD); and methods of treating patients with such compounds; wherein R1-R11 are as defined herein.
    Type: Application
    Filed: April 28, 2009
    Publication date: March 25, 2010
    Applicant: VANTIA LIMITED
    Inventors: David Michael Evans, Christine Elizabeth Allan, John Horton, David Philip Rooker